Clinical studies of tosufloxacin on chronic bacterial prostatitis

In a multicenter trial at 17 institutions, the usefulness of an oral dose of 300 mg of tosufloxacin (TFLX) twice a day for 14 days were assessed in the management of chronic bacterial prostatitis (CBP) diagnosed by Meares and Stamey method. Nineteen patients who were evaluated by the UTI criteria we...

Description complète

Détails bibliographiques
Publié dans:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 39(1993), 7 vom: 01. Juli, Seite 673-8
Auteur principal: Ikeuchi, T (Auteur)
Autres auteurs: Kawamura, N, Suzuki, K, Onodera, S, Osada, T, Hirano, A, Satomi, Y, Yoshimura, S, Yamamoto, Y
Format: Article
Langue:Japanese
Publié: 1993
Accès à la collection:Hinyokika kiyo. Acta urologica Japonica
Sujets:Clinical Trial English Abstract Journal Article Multicenter Study Anti-Infective Agents Fluoroquinolones Naphthyridines Tablets tosufloxacin GHJ553KQPS